weight reduction

Showing 1 posts of 1 posts found.

Orforglipron shows weight and glucose advantages over oral semaglutide in indirect comparison

October 23, 2026
Diabetes, Obesity, Peptide therapies, clinical trials, diabetes, weight reduction

Pharmaceutical firm Lilly’s orforglipron was associated with greater reductions in body weight and blood glucose than oral semaglutide in adults …

The Gateway to Local Adoption Series

Latest content